Turkish Scientists have Developed a Cardiac Muscle Tissue
Turkish scientists have developed artificial cardiac muscle tissue to enable the research of genetic heart diseases...
Turkish Scientists have Developed a Cardiac Muscle Tissue
Turkish scientists have developed artificial cardiac muscle tissue to enable the research of genetic heart diseases and the development of new treatment methods.
In the study, clinical work of which is conducted by Prof. Dr. Volkan Tuzcu and laboratory work of which by Asst. Prof. Dr. Esra Çağavi, heart tissue of sick origin and stimulated stem cells is produced using a Nobel Prize-winning technique "Reprogramming".
The study, conducted for the research of genetic heart diseases and the development of new treatment methods, is performed in Medipol University Regenerative and Restorative Medicine Research Center (REMER) with the support of TÜBİTAK.
In the study, blood cells taken from patients are reprogrammed by transforming into embryonic stem cells. It is aimed at modeling diseases and developing a source of cellular therapy by producing personal heart tissue in the laboratory from the stem cells developed.
It is aimed at developing the potential method and medicine to be used in the treatment of heart diseases through personal and unlimited special cells, thanks to the tissue.
The Founding Manager of REMER, Prof. Dr. Gürkan Öztürk: "Think about a child; we can develop a process that might change his life into a treatment option beneficial for him, starting from a blood sample and using the highest technology possible right now."
The project coordinator, Asst. Prof. Dr. Esra Çağavi: "These cells, when obtained from sick individuals, provide us both an unlimited source and a platform to do research on these diseases in the laboratory environment, which enables the modelling of the disease in the laboratory environment."
In the study, clinical work of which is conducted by Prof. Dr. Volkan Tuzcu and laboratory work of which by Asst. Prof. Dr. Esra Çağavi, heart tissue of sick origin and stimulated stem cells is produced using a Nobel Prize-winning technique "Reprogramming".
The study, conducted for the research of genetic heart diseases and the development of new treatment methods, is performed in Medipol University Regenerative and Restorative Medicine Research Center (REMER) with the support of TÜBİTAK.
In the study, blood cells taken from patients are reprogrammed by transforming into embryonic stem cells. It is aimed at modeling diseases and developing a source of cellular therapy by producing personal heart tissue in the laboratory from the stem cells developed.
It is aimed at developing the potential method and medicine to be used in the treatment of heart diseases through personal and unlimited special cells, thanks to the tissue.
The Founding Manager of REMER, Prof. Dr. Gürkan Öztürk: "Think about a child; we can develop a process that might change his life into a treatment option beneficial for him, starting from a blood sample and using the highest technology possible right now."
The project coordinator, Asst. Prof. Dr. Esra Çağavi: "These cells, when obtained from sick individuals, provide us both an unlimited source and a platform to do research on these diseases in the laboratory environment, which enables the modelling of the disease in the laboratory environment."